Concepedia

Author

N. P. GOULD

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

N Gould, N. P. GOULD, N. P. Gould, Nathalie Gould

20

Publications

299

Citations

7

H-Index

21

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)
NP

About

N. P. GOULD is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, medicinal chemistry, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

165

2

Natural Sciences

3

3

121

3

Biochemistry

2

2

60

4

Neurology

2

2

105

5

Chemical Biology

1

1

34

N. P. GOULD

×

6

Publications

281

Citations

6

H-Index

YearCitations

Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists

B. Evans, Kenneth E. Rittle, Mark G. Bock,

Journal of Medicinal Chemistry

1987

73

Agents for the treatment of brain edema. 2. [(2,3,9,9a-Tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)oxy]alkanoic acids and some of their analogs

Edward J. Cragoe, Otto W. Woltersdorf, N. P. GOULD,

Journal of Medicinal Chemistry

1986

61

Agents for the treatment of brain injury. 1. (Aryloxy)alkanoic acids

E. J. Cragoe, N. P. GOULD, Otto W. Woltersdorf,

Journal of Medicinal Chemistry

1982

44

Effectiveness of combined limonene and 4-hydroxyandrostenedione in the treatment of NMU-induced rat mammary tumours

SK Chander, AGB Lansdown, YA Luqmani,

British Journal of Cancer

1994

43

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 2. Structural modification of 7-(substituted aryl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives

William F. Hoffman, Alfred W. Alberts, Edward J. Cragoe,

Journal of Medicinal Chemistry

1986

34

Novel glutamic acid-derived cholecystokinin receptor ligands

Roger Freidinger, Willie L. Whitter, N. P. GOULD,

Journal of Medicinal Chemistry

1990

26

Page 1